CoChat

Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia

Open access
Yamada, Atsushi, Horimatsu, Takahiro, Okugawa, Yoshinaga, Nishida, Naoshi, Honjo, Hajime, Ida, Hiroshi, Kou, Tadayuki, Kusaka, Toshihiro, Sasaki, Yu, Yagi, Makato, Higurashi, Takuma, Yukawa, Norio, Amanuma, Yusuke, Kikuchi, Osamu, Muto, Manabu, Ueno, Yoshiyuki, Nakajima, Atsushi, Chiba, Tsutomu, Boland, C. Richard, Goel, Ajay · 2015 · Clinical Cancer Research
Cited by 156

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Purpose: Circulating microRNAs (miRNA) are emerging as promising diagnostic biomarkers for colorectal cancer, but their usefulness for detecting early colorectal neoplasms remains unclear. This study aimed to identify serum miRNA biomarkers for the identification of patients with early colorectal neoplasms. Experimental Design: A cohort of 237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects was analyzed in a three-step approach that included a comprehensive literature review for published biomarkers, a screening phase, and a validation phase. RNA was extracted from sera, and levels of miRNAs were examined by real-time RT-PCR. Results: Nine miRNAs (miR-18a, miR-19a, miR-19b, miR-20a, miR-21, miR-24, miR-29a, miR-92, and miR-125b) were selected as candidate biomarkers for initial analysis. In the screening phase, serum levels of miR-21, miR-29a, and miR-125b were significantly higher in patients with early colorectal neoplasm than in healthy controls. Elevated levels of miR-21, miR-29a, and miR-125b were confirmed in the validation phase using an independent set of subjects. Area under the curve (AUC) values for serum miR-21, miR-29a, miR-125b, and their combined score in discriminating patients with early colorectal neoplasm from healthy controls were 0.706, 0.741, 0.806, and 0.827, respectively. Serum levels of miR-29a and miR-125b were significantly higher in patients who had only small colorectal neoplasms (≤5 mm) than in healthy subjects. Conclusions: Because serum levels of miR-21, miR-29a, and miR-125b discriminated patients with early colorectal neoplasm from healthy controls, our data highlight the potential clinical use of these molecular signatures for noninvasive screening of patients with colorectal neoplasia. Clin Cancer Res; 21(18); 4234–42. ©2015 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-14-2793

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 156

Metadata

Authors
Yamada, A., Horimatsu, T., Okugawa, Y., Nishida, N., Honjo, H., Ida, H., Kou, T., Kusaka, T., Sasaki, Y., Yagi, M., Higurashi, T., Yukawa, N., Amanuma, Y., Kikuchi, O., Muto, M., Ueno, Y., Nakajima, A., Chiba, T., Boland, C. R., & Goel, A.
Venue
Clinical Cancer Research
Published
2015-09-14
Volume
21
Issue
18
Pages
4234-4242
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W1939801702
Cited by
156
References
5
FWCI
5.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-14-2793
The paper
Yamada, A., Horimatsu, T., Okugawa, Y., Nishida, N., Honjo, H., Ida, H., Kou, T., Kusaka, T., Sasaki, Y., Yagi, M., Higurashi, T., Yukawa, N., Amanuma, Y., Kikuchi, O., Muto, M., Ueno, Y., Nakajima, A., Chiba, T., Boland, C. R., & Goel, A. (2015). Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-14-2793

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.